CHELATION THERAPY HAS been around for decades as a treatment for toxic metal poisoning. But, there have also been claims that the therapy could help several other conditions. Experts aren't so sure.

ATLANTA, GA—More than a decade after the TACT trial reported an astonishing reduction in cardiovascular events post-MI with heavy metal chelation in a subset of diabetic patients, the TACT2 trial, ...

Jan. 22, 2003 -- Ethylenedinitrilo tetraacetic acid (EDTA) chelation therapy presumably reduces the progression of renal disease in patients with high normal lead levels and without diabetes, ...

Atherosclerotic cardiovascular disease (CVD) is highly prevalent and, despite therapeutic advances, remains a leading cause of morbidity and mortality. Many patients with CVD seek additional ...

ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed. Cumulative incidence of time ...

Chelation therapy to remove potentially toxic levels of lead from the blood was not associated with a reduction in cardiovascular events in post-myocardial infarction (MI) patients with diabetes in ...

With a result that is likely to surprise and baffle much of the mainstream medical community, a large NIH-sponsored trial has turned up the first substantial evidence in support of chelation therapy ...

MIAMI BEACH, Fla. — The new heart patient asked Dr. Gervasio Lamas if he thought chelation therapy was worth a try. “Of course not!” the cardiologist replied emphatically. His Harvard training had ...

PNEUMONOCONIOSIS associated with heavy-metal inhalation has long resisted most forms of therapy. The development of chelating agents offers a new approach to this problem. This report concerns our ...

Recently, there has been a growing interest in EDTA supplements due to the possible health benefits they provide. Ethylenediaminetetraacetic acid (EDTA), a chelating agent, bonds with heavy metals and ...